Become a top innovator for advanced and sustainable patient-centric healthcare, powered by our unique strength in science and technology and the alliance with Roche.
The TOP I 2030 ambition of Chugai Pharmaceutical Co., Ltd. is underpinned by Digital Technology, Research and Early Development, and Open Innovation. In Europe, each member of our team contributes towards these core pillars through our regional activities. Our Development and Study Management teams support early-stage research into new therapies, our Innovation team actively scout the European ecosystem to identify new trends in digital health, and across the region we seek to adopt an innovative approach that maximises business efficiency. Through this internal mindset our team continually seek to challenge the norm and find partnerships that enhance our capabilities, helping us to foster innovation for the benefit of patients.
Our team have a unique role in Europe to support Chugai Pharmaceutical Co., Ltd. to become a top innovator.
C-GB-00000895 | Date of Preparation: November 2023
Chugai Pharma Europe Ltd takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc. Furthermore, Chugai Pharma Europe Ltd will not be responsible for any damages resulting from the use of this website or the information presented on this website. For further details, please read the following “Privacy Statement” and “Important Information.”
Copyright © 2023 Chugai Pharma Europe Ltd. All rights reserved.